Penumbra, Inc.
PEN
$5.02 (-1.92%)
1D
1W
3M
1Y
5Y
ALL
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 2 days ago • PEN
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled TrialZacks Investment Research • 9 days ago • PEN
ITGR or PEN: Which Is the Better Value Stock Right Now?Zacks Investment Research • 9 days ago • PEN
Zacks Industry Outlook Penumbra, Integer and AngioDynamicsZacks Investment Research • 9 days ago • PEN
PEN Stock Rises Following the Launch of Ruby XL SystemZacks Investment Research • 12 days ago • PEN
3 Medical Instruments Stocks Winning Big With GenAI Amid Global GloomCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.